Quick Reference

n. a monoclonal antibody used in the treatment of severe psoriasis that has not responded to orally administered drugs or to PUVA; it inhibits activation of T lymphocytes. Efalizumab is administered by subcutaneous injection; side-effects include flulike symptoms. Trade name: Raptiva.

Subjects: Medicine and Health.

Reference entries